4 ms·
So the drug has been shown to reduce these amyloid plaques, but the trials have not conclusively demonstrated any effect on patient outcomes. The author then cl
by HPsquared 5y ago
So the drug has been shown to reduce these amyloid plaques, but the trials have not conclusively demonstrated any effect on patient outcomes. The author then claims it should be effectively banned for this reason. Why shouldn't someone be allowed to take it if they want to?
- jcranmer 5y agoThere's a history of drugs that reduced amyloid plaques, perhaps with even better efficiency than aducanumab (I don't recall exact details) yet still failed to demonstrate any effect on patient outcomes. The commentary that the trials haven't "conclusively demonstrated any effect" is an understatement. Recall that one of the trials outright failed the endpoint, and the attempt to reconcile that with the other trial smells strongly of statistical hogwash. The advisory committee rejected it wholesale, with not a single vote in favor and only one vote not in disfavor (i.e., abstention).
- jasonlaramburu 5y agoMy understanding is that aducanumab has shown the greatest efficacy of any beta amyloid blocker (at reducing beta amyloid, with the least side effects. It definitely has side effects (brain swelling in 40%), but other Beta amyloid blockers have proven largely intolerable.
- vajrabum 5y agoMost of the patients this could be prescribed to are on Medicare. At $56k per patient and 5.5 million patients that's $308Billion. Oh and the drug causes edema in the brain in 40% of patients who are APOE e4 carriers which will be overrepresented in the patient population. That edema lead to confusion and patient falls. The scientific advisory board voted 10:0 with one abstention against approval. I'd just as soon not pay for something that doesn't work and in some cases causes harm.
- shkkmo 5y agoI don't understand how a drug gets approved if the science board votes unanimously against it... who chose to override that decision?
- nceqs3 5y agoThe FDA.
- nceqs3 5y agoMEDICARE DOESN'T PAY LIST PRICES!
- NoImmatureAdHom 5y agoTHIS PERSON IS CORRECT https://www.rjhealth.com/2019/07/31/drug-pricing-101-reimbursement-rj-health-methodologies-drug-claims-code-level-unit-level-hcpcs-ndc/ https://www.rjhealth.com/2019/07/31/drug-pricing-101-reimbur...
- NoImmatureAdHom 5y agoI appreciate you doing the math! I'd appreciate it even more with sources for 5.5m :-)
- derbOac 5y agoSo then isn't the issue medicare reimbursement, not FDA approval? To be honest, this, along with several other things over the last year, has reinforced my perception that drug regulation in general is a failure and that the FDA needs to move away from an approval role (that is, approving the availability of the drug) to a truth-in-labeling role (that is, is this drug what the seller says it is).
- aliasEli 5y agoHow do you handle any medical claims by the manufacturer? Few consumers will be able to determine independently whether or not such claims are justified. How should consumers judge the quality of the research into this drug? How should they judge potential side-effects?
- gumby 5y ago> Why shouldn't someone be allowed to take it if they want to? That's the standard libertarian argument and we have an actual A/B experiment that shows what happens. People used to be able to market any old thing (such as "snake oil") to cure whatever they wanted to say. A regime was built up over time (culminating in 1963) that you had to demonstrate both safety and efficacy in order to sell a drug, and you could only describe the drug in ways you had demonstrated (which included manufacturing). In 1994 Orrin Hatch (he of copyright maximization and senator from a state with a lot of "natural" scammers") got a law passed to say that anything "natural" was exempt from any FDA rules and sellers could say whatever they want. And as a result unlocked a huge snake oil business that preys on people when they are feeling most vulnerable. Fortunately most of those things are harmless nonsense but sadly not all. If you decide there is no need to prove efficacy than nobody would spend time on it. And thus drug had its trials halted because nobody was being cured (not only do you not want to spend money on them, but it's unethical to expose people to side effects of a drug that doesn't help them. The FDA is saying that even though it's unethical to do in a trial it's OK to do in the market.
- PragmaticPulp 5y ago> Why shouldn't someone be allowed to take it if they want to? It's not entirely an issue of freedom. It's also about whether or not taxpayers have to pay Medicare to provide it. By some estimates, 1 in 9 people over the age of 65 have some degree of Alzheimer's. The cost of the drug is estimated at $56K per year. If we, the taxpayers, are now on the hook to pay $56K/year for up to 1 in 9 elderly people in the country for a drug that may not actually work and has some serious side effects, that's not good at all. Given the data we have, there's a significant probability that we'd be paying $56K/year to make these patients worse on average given the risk of serious side effects of the drug with negligible appreciable upside. That's a major problem. It might be possible for Medicare to deny this drug due to lack of efficacy, but that sounds like a political nightmare.
- shkkmo 5y agoThere should be a step between banning and approval. If you look at the history of hiv/aids drug approval it's pretty clear that there is significant harm that can be done by banning unapproved drugs. At the same time, removing the requirement to show efficacy to be approved is also quite obviously bad for the reasons outlined in the article. Why can't the company be allowed to provisionally sell the drug with the warning that the FDA has evaluated the drug as "unproven efficacy" until such a time as the follow up studies are completed?
- ceejayoz 5y agoWe have such a thing. https://www.fda.gov/news-events/public-health-focus/expanded-access https://www.fda.gov/news-events/public-health-focus/expanded...
- shkkmo 5y agoMy understanding is that while that helps in some cases, the restrictions on its applicability leave a lot of people high and dry.
- EamonnMR 5y agoThey could sell them as supplements but then they wouldn't be legally able to claim efficacy or be billed as medicine. They can't make nearly as much money without FDA approval.